Recent Updates
Recently added Catalysts
SMTI Positive Sentiment

Compatibility Assessment of BIASURGE® Advanced Surgical Solution with Implantable Materials and Closure Technologies

Thursday, May 23, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The study evaluates the compatibility of BIASURGE with blood clotting and various surgical materials, including bone cements and adhesives. It also assesses the product's effects on common prosthetic metals, finding no corrosive or oxidative properties. These findings suggest BIASURGE could enhance surgical outcomes.
Price reaction · baseline $30.28 (2024-05-22 close) · hit pre-market · clean, no other SMTI news in the window
day 0 close · peak
-4.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • BIASURGE shows compatibility with various surgical materials.
  • Research highlights potential benefits for surgical procedures.
  • No corrosive or oxidative properties were found.

Full Press Release Details

Authors: Bradley Rodier, PhD, Rebecca McMahon, PhD, Nina Bionda, PhD
This research study presents the results of a series of tests examining BIASURGE compatibility with blood clotting, various surgical materials including bone cements, and surgical adhesives or sealants. Additionally, it investigates whether BIASURGE exhibits any corrosive or oxidative properties when applied to common prosthetic metals.

Frequently Asked Questions

What does the study assess about BIASURGE?

The study assesses BIASURGE's compatibility with blood clotting and various surgical materials.

Are there any corrosive properties of BIASURGE?

The research found that BIASURGE exhibits no corrosive or oxidative properties.

What materials were tested for compatibility?

The study tested BIASURGE with bone cements and surgical adhesives or sealants.

ShareAdd on Google
Tags: SMTI Viatris Investor Conferences Healthcare BIASURGE surgical materials blood clotting prosthetic metals surgical adhesives
Last updated: May 23, 2024

Biotech snapshot

Cash runway
$29M liquidity · $0M/mo burn
Low dilution risk